Our review specifically identified key barriers and facilitators to recruiting CH residents into pharmacological trials. These findings can guide trial planning and support evidence-based care for this vulnerable population.
Subbarayan et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: